187 related articles for article (PubMed ID: 34772924)
1. MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness.
Min S; Lee YK; Hong J; Park TJ; Woo HG; Kwon SM; Yoon G
Cell Death Dis; 2021 Nov; 12(11):1076. PubMed ID: 34772924
[TBL] [Abstract][Full Text] [Related]
2. The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivity.
Zhao JW; Zhao WY; Cui XH; Xing L; Shi JC; Yu L
Clin Transl Oncol; 2024 Feb; 26(2):496-514. PubMed ID: 37407805
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of mammalian mitochondrial ribosomal protein genes.
Cheong A; Lingutla R; Mager J
Gene Expr Patterns; 2020 Dec; 38():119147. PubMed ID: 32987154
[TBL] [Abstract][Full Text] [Related]
4. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
[TBL] [Abstract][Full Text] [Related]
5. Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.
Lee YK; Lim JJ; Jeoun UW; Min S; Lee EB; Kwon SM; Lee C; Yoon G
J Biol Chem; 2017 Dec; 292(49):20208-20217. PubMed ID: 28978646
[TBL] [Abstract][Full Text] [Related]
6. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
7. Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.
Yang YM; Lee WH; Lee CG; An J; Kim ES; Kim SH; Lee SK; Lee CH; Dhanasekaran DN; Moon A; Hwang S; Lee SJ; Park JW; Kim KM; Kim SG
Oncogene; 2015 May; 34(22):2910-21. PubMed ID: 25065598
[TBL] [Abstract][Full Text] [Related]
8. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
9. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
[TBL] [Abstract][Full Text] [Related]
10. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
[TBL] [Abstract][Full Text] [Related]
11. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.
Kwon SM; Kim DS; Won NH; Park SJ; Chwae YJ; Kang HC; Lee SH; Baik EJ; Thorgeirsson SS; Woo HG
Carcinogenesis; 2013 Jul; 34(7):1543-50. PubMed ID: 23508637
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.
Shen Q; Cicinnati VR; Zhang X; Iacob S; Weber F; Sotiropoulos GC; Radtke A; Lu M; Paul A; Gerken G; Beckebaum S
Mol Cancer; 2010 Aug; 9():227. PubMed ID: 20799954
[TBL] [Abstract][Full Text] [Related]
13. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
[TBL] [Abstract][Full Text] [Related]
14. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
[TBL] [Abstract][Full Text] [Related]
15. Mitoribosomal defects aggravate liver cancer via aberrant glycolytic flux and T cell exhaustion.
Song BS; Moon JS; Tian J; Lee HY; Sim BC; Kim SH; Kang SG; Kim JT; Nga HT; Benfeitas R; Kim Y; Park S; Wolfe RR; Eun HS; Shong M; Lee S; Kim IY; Yi HS
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580931
[TBL] [Abstract][Full Text] [Related]
16. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
17. miR-3607, a biomarker of hepatocellular carcinoma invasion and aggressiveness: Its relationship with epithelial-mesenchymal transition process.
Hu WY; Wei HY; Liu LY; Li KM; Wang RB; Xu XQ; Feng R
IUBMB Life; 2020 Aug; 72(8):1686-1697. PubMed ID: 32311821
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.
Cui H; Zhang Y; Zhang Q; Chen W; Zhao H; Liang J
Cancer Med; 2017 Dec; 6(12):2932-2941. PubMed ID: 29047230
[TBL] [Abstract][Full Text] [Related]
19. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
[No Abstract] [Full Text] [Related]
20. MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells.
Sun X; Zhao S; Li H; Chang H; Huang Z; Ding Z; Dong L; Chen J; Zang Y; Zhang J
J Cell Physiol; 2017 Mar; 232(3):625-634. PubMed ID: 27333771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
